E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Unraveling the Molecular Determinants of Manual Therapy: An Approach to Integrative Therapeutics for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Espejo, José Andrés, García-Escudero, María, Oltra, Elisa · International journal of molecular sciences · 2018 · DOI
Quick Summary
This review examines how manual therapy—such as massage and physical manipulation—might help people with fibromyalgia and ME/CFS by studying what happens at the cellular and molecular level. The authors argue that manual therapy could work by triggering the body's natural healing responses, and they suggest it might be particularly helpful for ME/CFS patients because it can gently condition muscles without requiring strenuous exercise that typically worsens symptoms.
Why It Matters
This work addresses a critical gap for ME/CFS patients by proposing a scientific framework to explain how manual therapy might provide benefits without triggering post-exertional malaise (PEM)—a key concern for this population. Understanding the molecular mechanisms could help researchers and clinicians design safer, evidence-based therapeutic protocols tailored to ME/CFS pathophysiology.
Observed Findings
- Manual therapy can trigger systemic physiological responses despite being applied to localized, low-pain anatomic regions
- Mechanical-load responses involve gene expression changes that may have therapeutic relevance
- Manual therapy can provide gentle muscle conditioning without requiring strenuous exercise
- Physiotherapy protocols currently lack standardized parameters and appropriate controls in published literature
Inferred Conclusions
- Manual therapy may be suitable for integrative medicine programs treating FM and CFS/ME when properly standardized
- A molecular physiotherapy approach combining animal models, gene expression studies, and rigorous clinical trials could establish scientific legitimacy for manual therapy
- CFS/ME patients may particularly benefit from manual therapy because it avoids the strenuous physical demands that trigger symptom exacerbation
Remaining Questions
- What specific manual therapy protocols and parameters optimize molecular responses while minimizing symptom flare in ME/CFS patients?
- How can researchers design clinical trials that adequately measure both molecular changes and meaningful patient-reported outcomes in this population?
- Does manual therapy's proposed benefit apply to all ME/CFS subtypes, or are certain patient phenotypes more responsive?
What This Study Does Not Prove
This review does not establish that manual therapy definitively treats ME/CFS or fibromyalgia; it proposes a research framework and mechanism but presents no new clinical trial data. The authors do not prove causation between proposed molecular changes and clinical improvements. Importantly, it does not address individual patient variability or demonstrate that benefits outweigh risks for all ME/CFS patients.
Tags
Symptom:Post-Exertional MalaisePainFatigue
Biomarker:Gene Expression
Method Flag:PEM Not DefinedExploratory Only
Metadata
- DOI
- 10.3390/ijms19092673
- PMID
- 30205597
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →